Literature DB >> 7685635

An activator of calcium-dependent potassium channels isolated from a medicinal herb.

O B McManus1, G H Harris, K M Giangiacomo, P Feigenbaum, J P Reuben, M E Addy, J F Burka, G J Kaczorowski, M L Garcia.   

Abstract

Large-conductance calcium-dependent potassium (maxi-K) channels play an important role in regulating the tone of airway smooth muscle and the release of bronchoconstrictive substances from nerves in the lung. Crude extracts of Desmodium adscendens, a medicinal herb used in Ghana as a treatment for asthma, inhibit binding of monoiodotyrosine charybdotoxin (125I-ChTX) to receptor sites in bovine tracheal smooth muscle membranes that have been shown to be associated with maxi-K channels. Using this assay, three active components have been purified and identified by NMR and MS. Comparison with authentic samples revealed the three active components as the known triterpenoid glycosides dehydrosoyasaponin I (DHS-I), soyasaponin I, and soyasaponin III. The most potent of these compounds, DHS-I, is a partial inhibitor of 125I-ChTX binding (Ki = 120 nM, 62% maximum inhibition). Inhibition of 125I-ChTX binding is primarily due to a decrease in the observed maximum number of binding sites, with a smaller decrease in affinity. DHS-I increases the rate of toxin dissociation from its receptor, suggesting that modulation of ChTX binding occurs through an allosteric mechanism. DHS-I reversibly increases the open probability of maxi-K channels from bovine tracheal smooth muscle incorporated into planar lipid bilayers when applied to the intracellular, but not the extracellular, side of the membrane at concentrations as low as 10 nM. In contrast, DHS-I had no effect on several other types of potassium channels or membrane transporters. This natural product is the first example of a high-affinity activator of calcium-dependent potassium channels and is the most potent known potassium channel opener.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7685635     DOI: 10.1021/bi00075a002

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  44 in total

1.  BK channel activation by NS-1619 is partially mediated by intracellular Ca2+ release in smooth muscle cells of porcine coronary artery.

Authors:  H Yamamura; Y Ohi; K Muraki; M Watanabe; Y Imaizumi
Journal:  Br J Pharmacol       Date:  2001-02       Impact factor: 8.739

2.  Molecular basis of fast inactivation in voltage and Ca2+-activated K+ channels: a transmembrane beta-subunit homolog.

Authors:  M Wallner; P Meera; L Toro
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

3.  Molecular mechanism of pharmacological activation of BK channels.

Authors:  Guido Gessner; Yong-Mei Cui; Yuko Otani; Tomohiko Ohwada; Malle Soom; Toshinori Hoshi; Stefan H Heinemann
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-13       Impact factor: 11.205

4.  Prevention of rotavirus infections in vitro with aqueous extracts of Quillaja Saponaria Molina.

Authors:  Michael R Roner; Ka Ian Tam; Melody Kiesling-Barrager
Journal:  Future Med Chem       Date:  2010-07       Impact factor: 3.808

5.  Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors.

Authors:  J Onishi; M Meinz; J Thompson; J Curotto; S Dreikorn; M Rosenbach; C Douglas; G Abruzzo; A Flattery; L Kong; A Cabello; F Vicente; F Pelaez; M T Diez; I Martin; G Bills; R Giacobbe; A Dombrowski; R Schwartz; S Morris; G Harris; A Tsipouras; K Wilson; M B Kurtz
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

Review 6.  Vascular large conductance calcium-activated potassium channels: functional role and therapeutic potential.

Authors:  Birgit Eichhorn; Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-12       Impact factor: 3.000

Review 7.  Endothelial Ca+-activated K+ channels in normal and impaired EDHF-dilator responses--relevance to cardiovascular pathologies and drug discovery.

Authors:  Ivica Grgic; Brajesh P Kaistha; Joachim Hoyer; Ralf Köhler
Journal:  Br J Pharmacol       Date:  2009-03-19       Impact factor: 8.739

Review 8.  K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.

Authors:  Heike Wulff; Boris S Zhorov
Journal:  Chem Rev       Date:  2008-05       Impact factor: 60.622

9.  Cerebrovascular dilation via selective targeting of the cholane steroid-recognition site in the BK channel β1-subunit by a novel nonsteroidal agent.

Authors:  Anna N Bukiya; Jacob E McMillan; Alexander L Fedinec; Shivaputra A Patil; Duane D Miller; Charles W Leffler; Abby L Parrill; Alex M Dopico
Journal:  Mol Pharmacol       Date:  2013-03-01       Impact factor: 4.436

Review 10.  Vascular KCa-channels as therapeutic targets in hypertension and restenosis disease.

Authors:  Ralf Köhler; Brajesh P Kaistha; Heike Wulff
Journal:  Expert Opin Ther Targets       Date:  2010-02       Impact factor: 6.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.